abstract |
The present invention provides immunomodulatory proteins comprising ICOSL variants, and nucleic acids encoding these proteins. Immunomodulatory proteins have therapeutic utility for various immunological and oncological conditions. The present invention relates to compositions and methods for producing and using these proteins. |